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Introduction: Overweight and obesity in childhood and adolescence are associated with reduced breast cancer
risk, independent of adult body mass index (BMI). These associations may be mediated through breast density.
Methods: We prospectively examined associations of early life body fatness with adult breast density measured by
MRI in 182 women in the Dietary Intervention Study in Children (DISC) who were ages 25–29 at follow-up. Height,
weight, and other factors were measured at baseline (ages 8–10) and annual clinic visits through adolescence. We
used linear mixed-effects models to quantify associations of percent breast density and dense and non-dense breast
volume at ages 25–29 with quartiles of age-specific youth body mass index (BMI) Z-scores, adjusting for clinic, treatment
group, current adult BMI, and other well-established risk factors for breast cancer and predictors of breast density.
Results: We observed inverse associations between age-specific BMI Z-scores at all youth clinic visits and percent breast
density, adjusting for current adult BMI and other covariates (all p values <0.01). Women whose baseline BMI Z-scores
(at ages 8–10 years) were in the top quartile had significantly lower adult breast density, after adjusting for current
adult BMI and other covariates [least squares mean (LSM): 23.4 %; 95 % confidence interval (CI): 18.0 %, 28.8 %] compared
to those in the bottom quartile (LSM: 31.8 %; 95 % CI: 25.2 %, 38.4 %) (p trend <0.01). Significant inverse associations were
also observed for absolute dense breast volume (all p values <0.01), whereas there were no clear associations
with non-dense breast volume.
Conclusions: These results support the hypothesis that body fatness during childhood and adolescence may play
an important role in premenopausal breast density, independent of current BMI, and further suggest direct or
indirect influences on absolute dense breast volume.
Clinical Trials Registration Number: NCT00458588; April 9, 2007Introduction
Greater body fatness at young ages is associated with
substantially decreased risk of breast cancer both in
premenopausal and postmenopausal women [1–3], and
this association is independent of adult body mass index
(BMI) and other established breast cancer risk factors
[3]. Body fatness at young ages may affect breast cancer
risk through breast density, an established biomarker for* Correspondence: kbertran@hsph.harvard.edu
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creativecommons.org/publicdomain/zero/1.0/breast cancer risk [4] that refers to the proportion of
fibroglandular tissue (versus adipose tissue) in the
breast [5].
Although adult BMI is inversely related to breast dens-
ity, there has been little research focusing on the role of
body fatness at younger ages [6–11]. Since most breast
development occurs during puberty, body fatness during
this time period could have an important impact on
breast morphology and consequently breast density later
in life, influencing breast cancer risk through this
pathway. Results from recent studies [6, 7, 9, 10, 12]
support the hypothesis that body fatness at young
ages may influence breast density later in life. Becausearticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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women given risks associated with radiation exposure, few
studies have evaluated these associations in young pre-
menopausal women. Moreover, recent evidence suggests
that absolute dense and non-dense areas may have
independent effects on cancer risk [13–15]. Understanding
the possible differential associations of early life body fat-
ness with absolute density phenotypes could provide add-
itional insight into possible mechanisms underlying these
associations.
To examine whether body fatness during childhood
and adolescence is associated with percent breast density
and absolute dense and non-dense breast volume in
young adult women, we conducted a prospective analysis
among women in the Dietary Intervention Study in
Children 2006 (DISC06) Follow-up Study.
Methods
Study population
The original DISC was a multicenter, randomized con-
trolled trial to examine the safety and efficacy of a diet-
ary intervention to reduce serum low-density lipoprotein
cholesterol (LDL-C) in children [16–19]. Briefly, be-
tween 1988 and 1990, 663 healthy, prepubertal 8–10-
year-old children, including 301 girls, with elevated
LDL-C were recruited to six clinical centers and ran-
domized to a behavioral dietary intervention or usual
care control group. Children participated in annual
clinic visits until the trial was terminated in 1997, when
the average age of participants was 16.7 years, due to a
lack of treatment effect on LDL-C. In 2006–2008 when
participants were 25–29 years old, the DISC06 Follow-
up Study was conducted to evaluate longer-term effects
of the dietary intervention on biomarkers associated
with breast cancer risk in female participants. At the
time of the original DISC, assent was obtained from
participants; their parents/guardians provided informed
consent before randomization. Participants were re-
consented before the DISC06 follow-up visit. The
original DISC protocol was approved by an NHLBI-
appointed independent data and safety monitoring
committee and institutional review boards (IRBs) at
all participating clinical centers and the data coordinating
center. The DISC06 Follow-up Study protocol was ap-
proved by IRBs at the Fox Chase Cancer Center, participat-
ing clinical centers, and the data coordinating center
(please see Acknowledgments).
For this analysis, participants included 182 women
who enrolled in the original DISC between 1988 and
1990, when they were ages 8–10 years, and also partici-
pated in the DISC 2006 (DISC06) Follow-up Study,
when they were ages 25–29 years. Women who were
pregnant or breastfeeding within 12 weeks (n = 30) be-
fore their clinic visit, had breast implants or reductionsurgery (n = 16), or whose magnetic resonance imaging
(MRI) scan was missing or of poor quality (n = 32) were
excluded.
Data collection
During the original DISC, height and weight were mea-
sured at baseline and annual clinic visits by trained study
staff blinded to treatment assignment. Specifically,
height was measured using a stadiometer and weight
was measured on an electronic or beam balance scale.
Each measurement was made twice. A third measure-
ment was taken if the first two measurements were not
within allowable tolerances (0.5 cm for height and 0.2 kg
for weight) and the two closest values were averaged.
BMI was calculated as weight (kg)/height (m2) and
expressed as a Z-score relative to Centers for Disease
Control and Prevention (CDC) 2000 growth charts [20].
Information on demographic and other characteristics,
including medical history and reproductive factors, was
ascertained on annual questionnaires. More extensive
data, including three 24-h dietary recalls and physical
activity assessments, were collected at baseline and years
1, 3, 5 and last childhood visits [21, 22].
DISC06 follow-up visits took place at the original six
DISC clinics and were scheduled during the luteal phase
of the menstrual cycle when possible (>85 % of visits
occurred within 14 days of onset of next menses). Infor-
mation was updated and percent breast density was
assessed following a standardized protocol by non-
contrast MRI. Equipment standards at each site were
consistent with American College of Radiology guide-
lines for breast MRI [23] and required that imaging be
performed using a whole-body MRI scanner of 1.5 Tesla
or higher field strength and a dedicated breast imaging
radiofrequency coil. A standard image-acquisition proto-
col was prescribed consisting of two pulse sequences
performed in both the transaxial and coronal orienta-
tions with a 32–40-cm field of view for bilateral cover-
age: a three-dimensional fast gradient echo sequence
without fat suppression, and a three-dimensional fast
gradient echo sequence with fat suppression.
To ensure accuracy and uniformity of data acquisition
at the different clinical centers, MRI technologists at the
sites were individually trained (by CK) to recognize and
correct failures due to incomplete fat suppression,
motion artifacts, and inadequate breast coverage. In
addition, acceptable image quality on three volunteers was
required for site certification. Participant scans that were
inaccurate due to artifacts, motion or technique were
excluded (n = 21).
All MRI image data were processed at the University
of California, San Francisco by CK using customized
software to identify the chest wall-breast tissue boundary
and skin surface, and to separate breast fibroglandular
Table 1 Participant characteristics (at the DISC06 follow-up visit)
Descriptive characteristic n Mean (SD) or %
Age (y) 182 27.2 (1.0)
Percent dense breast volume (%) 182 27.6 (20.5)
Absolute dense breast volume (cm3) 182 104.2 (70.6)
Absolute non-dense breast volume (cm3) 182 413.5 (364.3)
Body mass index (BMI) (kg/m2) 182 24.4 (5.4)
Height (cm) 182 165.3 (6.4)
BMI Z-score at 8–10 years old 182 0.23 (0.90)
Age at menarche (y) 182 12.9 (1.3)
Duration of hormonal contraceptive use (y)a 171 5.6 (3.5)
Race
White 164 90.1 %
Non-white 18 9.9 %
Education
High school, vocational, or technical school 18 9.9 %
Some college 44 24.2 %
College/Bachelor’s 95 52.2 %
Graduate school 25 13.7 %
Number of live births
0 129 73.1 %
1 30 16.5 %
2+ 23 12.6 %
Ever breast fed (among parous)
Yes 40 75.4 %
No 13 24.5 %
Hormonal contraceptive use
Never 11 6.0 %
Former 66 36.3 %
Current 105 57.7 %
Family history of breast cancer
Yes 7 3.9 %
No 171 96.1 %
Alcohol consumption
Never/former 16 8.8 %
Current, <3 drinks per week 71 39.0 %
Current, 3–<6 drinks per week 33 18.1 %
Current, 6– <10 drinks per week 40 22.0 %
Current, 10+ drinks per week 22 12.1 %
Smoking history
Never 100 55.0 %
Former 38 20.9 %
Current 44 24.2 %
Treatment assignment
Intervention 87 47.8 %
Usual care 95 52.2 %
aAmong current or former hormonal contraceptive users
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fuzzy C-means clustering [24]. Total volumes of fibro-
glandular and fatty tissue were computed separately for
each breast and averaged for analysis. Outcomes of
interest were percent dense breast tissue (ratio of fibro-
glandular volume to total volume of the breast), total
volume of dense tissue (fibroglandular volume), and
total volume of non-dense tissue (fatty breast tissue
volume).
Statistical analyses
We used linear mixed-effects models to examine the as-
sociation between percent breast density at ages 25–29
(outcome) and body mass index (BMI) Z-scores at base-
line (ages 8–10 years) (predictor). The analysis was re-
peated, changing the predictor to BMI Z-score at each
annual clinic visit during childhood and adolescence.
For our predictor, body fatness during childhood,
we created quartiles of age- and female-specific BMI
Z-scores computed from CDC growth charts [20]. A
linear mixed-effects model was fit by maximum likeli-
hood with clinic included as a random effect and empir-
ical (“robust”) standard errors to allow for correlated
outcomes within clinics. We considered potential con-
founding by the following variables: current BMI [25],
age at menarche, number of live births [26], duration of
hormone use [26], menstrual cycle day, height [25], alco-
hol consumption, race, education, moderate to intense
physical activity [22], smoking status, and family history
of breast cancer. Fully adjusted multivariable models in-
clude fixed-effect covariates that are well-established risk
factors for breast cancer (i.e., age at menarche, duration
of hormone use, race, and alcohol consumption) and
those that were statistically significantly associated with
density when included (current BMI, current BMI-
squared, number of live births, education, smoking
status, and family history of breast cancer). Categorical
covariates were categorized as shown in Table 1.
The association between quartiles of childhood BMI
Z-scores and adult breast density was quantified by
adjusted least squares means and 95 % confidence in-
tervals (CIs). Tests for trend and estimates of differ-
ences in adult breast density per youth BMI Z-score
(i.e., per standard deviation of BMI) were based on
models including childhood or adolescent BMI Z-score as
a continuous variable.
The same analytic approach was used to examine
the alternative outcomes of absolute dense and non-
dense tissue; to improve normality, we applied a natural
log-transformation to absolute measures of density
phenotypes and for consistency with prior literature.
Because of the log-transformation, we applied Duan’s
“smearing estimate” to back-transform estimates to ori-
ginal (untransformed) units of cm3; this method adjusts
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parametric or generalized linear models [27].
In secondary, post hoc analyses, we explored the
possible independent associations of childhood and
adolescent BMI at different ages with adult breast
density. First, we fit a model that mutually adjusted
for BMI Z-score at each age. Measures of BMI during
childhood and adolescence were strongly correlated,
which could lead to multicollinearity or model instability.
To evaluate possible multicollinearity, we fit ordinary least
squares regression models, including all BMI Z-scores
during youth visits and BMI at follow-up to calculate vari-
ance inflation factors (VIFs). All VIFs for the age-specific
BMI variables were <10, suggesting that multicollinearity
is not a substantial concern in these analyses [28–32].
Second, we cross-classified categories of lean versus
heavy body type in childhood/adolescence versus follow-
up (dichotomized at the median BMI Z-scores: 0.38
and −0.25, respectively) and compared average per-
cent breast density among women who were lean at
both time points with those who were heavy at both
time points or whose body fatness changed (e.g., lean
to heavy or heavy to lean).
Results
Among the 182 women, the mean age was 27.2 years and
mean adult BMI was 24.4 kg/m2 at the DISC06 follow-up
visit. On average, mean BMI Z-score at baseline at
ages 8–10 years was 0.23. The majority of women were
white (90.1 %), had high levels of education (>90 % had
at least some college), and were nulliparous (73.1 %) at
the time of follow-up. Mean percent dense breast volume
was 27.6 % (standard deviation, 20.5) (Table 1; full distri-
butions of breast density metrics and BMI are shown in
Figures S1a and Figure S1b in Additional file 1). OtherFig. 1 Difference in percent dense volume at the DISC06 follow-up visit pecharacteristics of the study population are shown in
Table 1. Table S1 in Additional file 2 shows selected de-
scriptive characteristics of the study population over each
of the five youth DISC clinic visits with more extensive
data collection; Table S2 in Additional file 2 shows the
high correlations between BMI measured at the various
study time points; Table S3 in Additional file 2 shows cor-
relations between BMI at each visit with breast density
measures.
We observed strong, significant inverse associations
between the age-specific BMI Z-score at all clinic visits
during childhood and adolescence and percent breast
density in adulthood (all p values <0.01) (Fig. 1). Because
of similar patterns in associations across youth clinic
visits, in Table 2 we present results from simple and
multivariable adjusted models only for baseline, Year 3,
Year 5, and last clinic visit. Associations were attenuated
upon adjustment for current adult BMI (Model 2), but
remained statistically significant. For example, women
whose BMI Z-scores, measured when they were between
8 and 10 years old, were in the top quartile of the cohort
had significantly lower BMI-adjusted breast density
(least squares mean: 23.7 %; 95 % confidence interval:
19.3 %, 28.0 %) compared to those in the bottom
quartile (least squares mean: 31.3 %; 95 % confidence
interval: 25.0 %, 37.6 %) (p trend <0.01). While number
of live births, duration of hormonal contraceptive use,
educational attainment, smoking status, and family
history of breast cancer were significant predictors of
percent breast density in the DISC06 cohort, inclusion
of these variables in the models did not substantially
change estimates of the associations between child-
hood and adolescent BMI and adult breast density.
Further, we did not observe evidence of confounding
by other suspected predictors of breast density, suchr unit increase in body mass index (BMI) Z-score, by youth clinic visits
Table 2 Least squares mean and 95 % confidence interval (CI) for percent dense breast volume at the DISC06 follow-up visit according
to quartile of age-specific youth body mass index (BMI) Z-score
Quartile of age-specific youth BMI Z-score: Q1 Q2 Q3 Q4 Change in adult percent
breast density per unit
youth BMI Z-score
p value*
BMI at baseline visit (ages 8–10) Model 1 40.9 (34.6, 47.2) 32.9(30.0, 35.8) 23.6 (19.6, 27.6) 13.1 (9.4, 16.8) −11.1 <0.01
n = 182 Model 2 31.3 (25.0, 37.6) 28.9 (26.6, 31.3) 26.7 (22.1, 31.3) 23.7 (19.3, 28.0) −2.7 <0.01
Model 3 31.8 (25.2, 38.4) 29.0 (26.0, 32.0) 26.2 (22.2, 30.1) 23.4 (18.0, 28.8) −3.1 <0.01
BMI at Year 3 visit (ages 11–13) Model 1 43.3 (36.7, 50.0) 34.6 (27.5, 41.8) 19.7 (16.8, 22.6) 12.8 (9.9, 15.7) −12.9 <0.01
n = 170 Model 2 33.8 (27.6, 40.0) 30.8 (24.8, 36.8) 24.1 (21.5, 26.8) 21.8 (18.6, 24.9) −5.1 <0.01
Model 3 34.5 (28.2, 40.7) 30.4 (26.5, 34.2) 25.0 (22.3, 26.9) 21.1 (18.6, 23.5) −5.4 <0.01
BMI at Year 5 visit (ages 13–15) Model 1 44.5 (38.7, 50.2) 39.0 (33.0, 44.9) 18.7 (15.0, 22.4) 9.9 (6.8, 13.0) −15.5 <0.01
n = 153 Model 2 35.4 (30.1, 40.8) 31.8 (26.4, 37.2) 22.7 (18.6, 26.9) 21.6 (14.9, 28.2) −6.2 <0.01
Model 3 34.5 (29.3, 39.7) 31.6 (19.3, 28.5) 23.9 (19.3, 28.5) 21.3 (14.8, 27.7) −6.2 <0.01
BMI at last visit (ages 15–17) Model 1 44.7 (37.4, 51.9) 36.0 (30.9, 41.1) 23.9 (19.9, 28.0) 11.0 (10.0, 12.0) −14.0 <0.01
n = 159 Model 2 32.3 (26.6, 38.0) 30.4 (23.4, 37.5) 29.0 (24.6, 33.4) 23.8 (22.0, 25.5) −3.4 <0.01
Model 3 32.1 (26.0, 38.1) 30.7 (24.6, 36.8) 29.0 (23.2, 34.9) 23.3 (20.8, 25.8) −3.6 <0.01
Cut points for quartiles are: baseline Z-BMI −1.9 to 0.47, −0.46 to 0.27, 0.28 to 0.98, 0.98 to 1.85; Year 3 Z-BMI −2.4 to 0.37, −0.34 to 0.34, 0.35 to 1.14, 1.15 to 2.17;
Year 5 visit −2.2 to 0.21, −0.21 to 0.37, 0.38 to 1.09, 1.53 to 2.19; Last visit −2.25 to 0.26, −0.23 to 0.30, 0.33 to 0.98, 0.99 to 2.13
Model 1 Least squares means estimated from linear mixed-effects models including clinic as a random effect and treatment group as a fixed effect
Model 2 Least squares means estimated from linear mixed-effects models including clinic as a random effect and adjusted for treatment group and current adult
BMI (continuous, kg/m2) as fixed effects
Model 3 Least squares means estimated from linear mixed-effects models including clinic as a random effect and adjusted for treatment group, current adult BMI
(continuous, kg/m2), number of live births, duration of hormone use, age at menarche, race, education, alcohol consumption, smoking status, and family history of
breast cancer, as fixed effects (4 missing)
*Test for trend
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(Table 2; Model 3). In these models, the decrease in
percent breast density ranged from 3.1 to 6.2 percent-
age points per 1-unit increase in childhood or adoles-
cent BMI Z-score (i.e., per standard deviation of
childhood or adolescent BMI).
We observed the strongest associations for the Year 5
clinic visit when girls were ages 13–15, during puberty
for most of them. Therefore, in secondary analyses, we
fit a multivariable model including BMI Z-score at the
five youth clinic visits and current adult BMI Z-score to
assess the possible independent associations of BMI
at various ages in childhood and adolescence with
young adult percent breast density. In these models,
the strongest inverse associations were observed for
BMI Z-score at the Year 3 visit (ages 11–13) and current
BMI Z-score. These variables were statistically signifi-
cantly independently associated with breast density
(differences of −6.7 and −17.0 percentage points per
standard deviation of BMI, respectively; p values <0.01
in mutually adjusted model).
To further explore changes in BMI over time associ-
ated with breast density, we considered cross-classified
categories of lean versus heavy in childhood/adolescence
(Year 5 visit) versus adult follow-up and observed that
women who were heavier at both time periods had the
lowest breast density (mean =11.0 %) while those whowere leaner at both time periods had the highest breast
density (mean = 42.8 %). Those who were lean in child-
hood and heavy in adulthood and vice versa had inter-
mediate values for breast density (26.5 % and 24.1 %,
respectively) (Fig. 2a).
In separate analyses, we observed significant inverse
associations between childhood/adolescent BMI and
adult absolute dense breast volume (p values <0.01)
(Table 3). In these analyses, there was little evidence of
confounding by adult BMI or any of the other covariates.
Each unit increase in youth BMI Z-score was associated
with a 24–38 % lower dense breast volume. The stron-
gest association was for BMI in Year 5 at ages 13–15.
Indeed, in mutually adjusted models, BMI at this time
point had the lowest p value; however, none were
statistically significant when all were included in the
same model (data not shown). Considering joint cat-
egorizations of body fatness in childhood/adolescence
(Year 5) and adult follow-up, we observed that women
who were heavy in adolescence had lower mean ab-
solute dense tissue volume while women who were
lean in adolescence had higher absolute dense breast
volume, regardless of their body fatness in adulthood
(Fig. 2b). There were no clear associations between
childhood or adolescent BMI and absolute non-dense
(fat) breast volume, after adjusting for current adult
BMI (Table 4).
ab
Fig. 2 a Mean percent breast density by body fatness in adolescence and at follow-up. b Mean absolute dense breast volume by body fatness in
adolescence and at follow-up
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In summary, we confirmed significant inverse associa-
tions between body fatness during childhood and adoles-
cence and percent breast density in adult women ages
25–29, independent of current adult BMI [25], con-
sistent with most [6–11] but not all [33, 34] previous
studies in this area. Significant inverse associations
were observed for absolute dense breast volume (all
p values <0.01), whereas there were no clear associa-
tions of early life body fatness with non-dense breast
volume.
Early life may be a time of increased susceptibility to
exposures and host factors that influence breast cancerrisk [35]. Mammary gland cells undergo rapid prolifera-
tion during puberty, which could explain why exposures
during this time period might be important for breast
density and breast cancer risk [35–37]. The suggestion
of somewhat stronger associations between childhood
BMI during puberty (ages 13–15) and adult percent
breast density supports the hypothesis that body fat-
ness could influence breast cancer risk through ef-
fects on breast density. A register-based cohort study
in Denmark reported strong inverse associations between
youth BMI, especially at age 13, and mammographic
density at a mean age of 54.6 years [38]. Further, the au-
thors reported significant associations between BMI at
Table 3 Mean and 95 % confidence interval (CI) for absolute dense breast volume (cm3) at the DISC06 follow-up visit according to
quartile of age-specific youth body mass index (BMI) Z-score
Quartile of age-specific youth BMI Z-score: Q1 Q2 Q3 Q4 % change in dense
breast volume per unit
youth BMI Z-score
p value*
BMI at baseline visit (ages 8–10) Model 1 155.5 (132.8, 182.1) 110.6 (98.2, 124.5) 102.2 (80.6, 129.7) 63.1 (44.9, 88.9) −28.1 % <0.01
n = 182 Model 2 142.8 (117.5, 173.5) 107.7 (95.5, 121.4) 105.9 (83.2, 134.8) 68.2 (47.1, 98.9) −22.9 % <0.01
Model 3 145.0 (116.1, 181.2) 109.4 (95.0, 126.1) 95.6 (74.5, 122.7) 64.9 (45.7, 92.0) −25.2 % <0.01
BMI at Year 3 visit (ages 11–13) Model 1 154.1 (140,9, 168.4) 127.9 (103.6, 157.7) 91.0 (77.8, 106.3) 59.8 (38.0, 94.0) −31.6 % <0.01
n = 170 Model 2 142.2 (124.4, 162.6) 126.0 (100.3, 158.3) 95.0 (78.6, 114.9) 63.1 (38.0, 104.7) −29.5 % <0.01
Model 3 147.2 (118.2, 183.2) 120.4 (103.7, 139.7) 89.4 (74.4, 107.4) 58.5 (38.1, 89.8) −32.3 % <0.01
BMI at Year 5 visit (ages 13–15) Model 1 161.2 (131.4, 197.7) 128.7 (118.1, 140.4) 82.9 (69.1, 99.5) 56.1 (34.6, 90.8) −35.6 % <0.01
n = 153 Model 2 166.4 (132.4, 209.2) 133.5 (120.1, 148.3) 84.6 (69.9, 102.3) 51.4 (26.5, 99.7) −36.9 % <0.01
Model 3 156.2 (129.5, 188.5) 121.7 (105.0, 141.0) 85.2 (67.9, 107.0) 48.8 (28.0, 85.0) −38.1 % <0.01
BMI at last visit (ages 15–17) Model 1 152.8 (126.9, 183.8) 123.7 (97.2, 157.4) 97.6 (70.0, 135.4) 65.9 (52.8, 82.2) −28.8 % <0.01
n = 159 Model 2 138.9 (110.0, 175.5) 120.1 (89.6, 160.9) 102.5 (75.2, 139.8) 70.6 (58.7, 84.9) −23.7 % <0.01
Model 3 130.3 (97.6, 173.8) 118.8 (88.4, 159.6) 97.6 (73.6, 129.3) 66.2 (52.1, 84.0) −23.7 % <0.01
Model 1 Means estimated from linear mixed-effects models including clinic as a random effect and treatment group as a fixed effect
Model 2 Means estimated from linear mixed-effects models including clinic as a random effect and adjusted for treatment group and current adult BMI as
fixed effects
Model 3 Means estimated from linear mixed-effects models including clinic as a random effect and adjusted treatment group, current adult BMI, number of live
births, duration of hormone use, age at menarche, race, education, alcohol consumption, smoking status, family history of breast cancer, and log-non-dense area
as fixed effects
*Test for trend
Bertrand et al. Breast Cancer Research  (2015) 17:95 Page 7 of 10age 13 and risk of breast cancer that were attenuated
upon additional adjustment for mammographic density,
suggesting that density could mediate associations
between early life BMI and breast cancer risk [38].
In contrast, however, the possible mediating effect ofTable 4 Mean and 95 % confidence interval (CI) for absolute non-d
to quartile of age-specific youth body mass index (BMI) Z-score
Quartile of age-specific youth BMI Z-score: Q1 Q2
BMI at baseline visit (ages 8–10) Model 1 252.8 (209.2, 305.5) 308.4 (242.4, 392.5)
n = 182 Model 2 356.2 (294.2, 431.1) 328.2 (300.0, 359.0)
Model 3 351.4 (291.1, 424.2) 325.9 (290.9, 351.3)
BMI at Year 3 visit (ages 11–13) Model 1 217.8 (166.7, 284.6) 292.8 (226.3, 378.8)
n = 170 Model 2 317.4 (244.5, 412.1) 322.6 (272.5, 381.9)
Model 3 313.4 (241.2, 407.3) 310.2 (267.3, 360.1)
BMI at Year 5 visit (ages 13–15) Model 1 203.4 (173.5, 238.5) 214.7 (166.8, 276.5)
n = 153 Model 2 318.0 (263.0, 384.5) 305.3 (247.2, 377.1)
Model 3 310.2 (271.6, 354.3) 291.6 (247.0, 344.1)
BMI at last visit (ages 15–17) Model 1 191.8 (154.8, 237.7) 243.4 (216.1, 274.2)
n = 159 Model 2 328.4 (277.1, 389.3) 293.1 (261.7, 328.3)
Model 3 326.5 (286.6, 372.1) 286.7 (257.0, 319.9)
Model 1 Means estimated from linear mixed-effects models including clinic as a ran
Model 2Means estimated from linearmixed-effectsmodels including clinic as a randomeffec
Model 3 Means estimated from linear mixed-effects models including clinic as a ran
births, duration of hormone use, age at menarche, race, education, alcohol consum
fixed effects
*Test for trendmammographic density on the association of youth
body fatness with breast cancer risk in the Nurses’ Health
Studies was weak [8].
Increasing evidence points to independent effects of
absolute dense and non-dense tissue [15]. While percentense breast volume (cm3) at the DISC06 follow-up visit according
Q3 Q4 % change in non-dense
breast volume per unit
youth BMI Z-score
p value*
462.7 (425.1, 503.7) 656.4 (573.4, 751.6) 47.7 % <0.01
329.5 (282.9, 383.7) 285.2 (244.6, 332.5) −8.6 % 0.04
290.2 (243.5, 345.8) 290.2 (243.5, 345.8) −8.6 % <0.01
531.7 (430.4, 656.9) 624.5 (581.7, 670.5) 60.0 % <0.01
352.9 (321.8, 387.1) 299.5 (262.3, 341.9) −3.0 % 0.64
342.9 (313.0, 275.7) 311.0 (278.5, 347.3) −1.0 % 0.80
502.3 (424.2, 594.8) 772.1 (652.2, 913.9) 84.0 % <0.01
365.7 (321.7, 415.8) 287.6 (242.6, 340.9) −3.0 % 0.71
356.3 (300.8, 421.9) 303.3 (267.9, 343.6) 0.8 % 0.85
460.8 (386.1, 550.0) 753.4 (702.2, 808,3) 80.4 % <0.01
329.1 (275.3, 393.5) 297.2 (270.4, 326.8) −2.0 % 0.60
317.0 (258.9, 388.2) 304.4 (279.2, 331.8) 0.1 % 0.98
dom effect and treatment group as a fixed effect
t and adjusted for treatment group and current adult BMI as fixed effects
dom effect and adjusted treatment group, current adult BMI, number of live
ption, smoking status, family history of breast cancer, and log-dense area as
Bertrand et al. Breast Cancer Research  (2015) 17:95 Page 8 of 10breast dense area has been considered a stronger pre-
dictor of breast cancer risk than absolute area measures
[15], recent evidence suggests that volumetric measures
may be more predictive than area measures and, further,
that absolute dense volume may be a better indicator of
breast cancer risk than percent dense volume [39].
Current BMI has been inversely associated with mea-
surements of absolute dense breast tissue [14, 25] and
positively associated with absolute non-dense (fat) tissue
[14]. We observed strong inverse associations between
childhood and adolescent BMI and young adult dense
breast volume but no associations with non-dense vol-
ume. These findings suggest the possibility of a direct or
indirect influence of body fatness in early life on breast
tissue composition, driven by the amount of dense tis-
sue. Further, the observed associations were independent
of established reproductive risk factors for breast cancer.
In a prior analysis within DISC06, after adjustment for
childhood BMI, current BMI was inversely associated
with percent breast density via its positive association
with absolute non-dense (fat) breast volume, while there
was no association of current BMI with absolute dense
breast tissue volume [25], providing further evidence
that the influence of adiposity on breast tissue compos-
ition differs over the life course.
Hypothesized mechanisms for the association between
childhood or adolescent body fatness and breast density and
cancer risk could include hormonal pathways. For example,
levels of some sex steroid hormones may be higher in girls
who are heavier [40, 41] and may be associated with earlier
differentiation of breast tissue, which could lead to reduced
risk of cancer [42, 43]. Body fatness during childhood and
adolescence could decrease breast cancer risk via effects on
ovarian function. Specifically, obesity suppresses ovarian
function, leading to fewer ovulatory menstrual cycles and
decreased circulating levels of estrogens and progesterone
[44, 45]. Early life body fatness could also influence breast
density and cancer risk through altered levels of insulin-like
growth factor-1 (IGF-1): increased weight during childhood
is directly associated with IGF-1 measured concurrently
[46, 47] but early life body size was inversely correlated with
IGF-1 levels measured later in adulthood in the Nurses’
Health Study [48], suggesting a possible pathway linking
childhood/adolescent body fatness, mammographic density,
and breast cancer risk. However, IGF-1 has been inconsist-
ently associated with mammographic density in previous
studies [49–55]. Of note, prior studies have demonstrated
that childhood adiposity is inversely related to growth vel-
ocity [56]. Given that slower growth velocity is associated
with lower risk of breast cancer [1, 57], breast density could
represent a possible link between these findings and a bio-
logic pathway to breast cancer risk. Finally, other currently
unidentified influences of fat on mammary gland develop-
ment are possible. Consistent with our findings, inducedobesity in mice fed a high-fat diet in the pubertal period was
associated with stunted mammary ductal growth and re-
duced mammary epithelial cell proliferation [58]. Interac-
tions of diet and body fatness in early life warrant further
investigation [21].
This analysis has some important potential limitations.
First, current BMI is a strong negative predictor of breast
density, and youth BMI is positively associated with
current BMI. Adjustment for current adult BMI substan-
tially attenuated associations between childhood and ado-
lescent BMI and percent breast density. While associations
remained statistically significant, we cannot rule out pos-
sible residual confounding by current BMI. However, the
strong inverse associations between childhood and adoles-
cent BMI and absolute dense breast volume (versus non-
dense volume) are not consistent with the idea that early
life body fatness is merely a proxy for adult adiposity. Sec-
ond, strong correlations between BMI measured at succes-
sive youth clinic visits make it difficult to disentangle
effects at a specific age or developmental period. Although
we did not detect evidence of multicollinearity in these
models, it remains a potential theoretical concern and may
limit our interpretation of age-specific findings and could
have contributed to attenuated non-significant findings for
absolute non-dense breast area. Third, because the original
DISC study population excluded children whose weight-
for-height was greater than the 90th percentile or lower
than the 5th percentile at baseline [16], our findings may
not be generalizable to very lean or very obese children.
Finally, only seven women reported a family history of
breast cancer at the time of follow-up; because their family
members may not have developed breast cancer yet, there
is potential misclassification of this variable.
Major strengths of this study include its prospective
design and objective and repeated measures of childhood
and adolescent weight and height whereas previous stud-
ies have been mostly based on retrospective recall and
relative body fatness (e.g., somatotype). In addition, we
had detailed questionnaire information and the ability to
adjust for many potential confounders. Systematic mea-
surement of breast density via MRI afforded us the ability
to consider dense versus non-dense breast volume separ-
ately, which provides additional information suggesting ef-
fects of youth body fatness on breast tissue composition.
Finally, this study is among the few studies to evalu-
ate these associations in young premenopausal women
ages 25–29; most previous studies focused on postmeno-
pausal women and older premenopausal women.
Conclusions
In conclusion, these results support the hypothesis that
body fatness during childhood and adolescence may play
an important role in premenopausal breast density, inde-
pendent of current adult BMI. Given strong inverse
Bertrand et al. Breast Cancer Research  (2015) 17:95 Page 9 of 10associations with absolute dense tissue volume and lack
of association with non-dense volume, our findings fur-
ther suggest direct or indirect influences of earlier life
adiposity on absolute dense breast volume. Further re-
search is warranted to evaluate the possible biological
mechanisms underlying these associations and to as-
sess associations with later premenopausal breast
density measurements and how changes in breast density
over the life course may relate to future breast cancer risk.
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